Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study
SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism. Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The lipid profile is a less robust biochemical marker than apolipoproteins, components of lipoproteins. However, the association of ap...
Main Authors: | Floran Begue, Kévin Chemello, Bryan Veeren, Brice Lortat-Jacob, Alexy Tran-Dinh, Nathalie Zappella, Aurelie Snauwaert, Tiphaine Robert, Philippe Rondeau, Marie Lagrange-Xelot, Philippe Montravers, David Couret, Sébastien Tanaka, Olivier Meilhac |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/5/4605 |
Similar Items
-
First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation
by: Sébastien Tanaka, et al.
Published: (2022-03-01) -
Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1
by: Karen Y.Y. Fung, et al.
Published: (2024-04-01) -
Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
by: John H. Contois, et al.
Published: (2023-08-01) -
Evaluating the relation between serum apolipoprotein B (apo B), apolipoprotein A (apo A) and apo B/apo A ratio with diabetic retinopathy in a sample of type 2 Egyptian diabetic patient
by: Salwa Seddik Hosny, et al.
Published: (2023-08-01) -
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
by: Jennifer Behbodikhah, et al.
Published: (2021-10-01)